Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Billionaire Ken Fisher’s 5 Most Notable Moves for 2026

In this article, we discuss billionaire Ken Fisher’s 5 most notable moves for 2026. If you want to read our detailed analysis of these stocks, go directly to Billionaire Ken Fisher’s 15 Most Notable Moves for 2026.

5. Cisco Systems, Inc. (NASDAQ:CSCO)

Fisher Asset Management’s Stake: $246 Million

Cisco Systems, Inc. (NASDAQ:CSCO) designs, develops, and sells technologies that help to power, secure, and draw insights from the internet in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company offers data center switching, network security, identity and access management, and secure access service edge.

4. Amgen Inc. (NASDAQ:AMGN)

Fisher Asset Management’s Stake: $296 Million   

Amgen Inc. (NASDAQ:AMGN) is also a staple in the 13F portfolio of Fisher Asset Management. The fund has held a small position in the company since early 2010. This position remained relatively stable through the decade and half since 2010. However, at the end of 2024 and in 2025, the fund has aggressively upped this stake. In the third and fourth quarter of 2025, the position has more than doubled compared to filings for the second quarter of 2025. At the end of the fourth quarter of 2025, the stake comprised close to 900,000 shares.

Latest reports suggest that Amgen Inc. (NASDAQ:AMGN) is the latest drug company that has agreed to sell medicines on TrumpRx, a government-run direct-to-consumer platform for pharmaceutical products. Per Fox News, a total of 54 prescription drugs from six pharma companies will be available on the site. The platform had launched last month with many drug giants agreeing to sell their products on the site for cash-paying customers as part of US President Donald Trump’s Most Favored Nation (MFN) drug pricing policy.

Amgen Inc. (NASDAQ:AMGN) discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis, as well as Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers.

3. HDFC Bank Limited (NYSE:HDB)

Fisher Asset Management’s Stake: $433 Million

HDFC Bank Limited (NYSE:HDB) is one of the few foreign companies that occupy a prominent position in the 13F portfolio of Fisher Asset Management. Fisher has held a stake in this banking stock for over a decade and a half. At its peak in the second quarter of 2016, this holding comprised more than 32 million shares. Since then, the fund has trimmed this stake steadily, bringing it down to nearly 12 million shares at the end of the fourth quarter of 2025. Compared to filings for the third quarter of 2025, the fund increased its position in the firm by close to 30% between October and December of last year.

In 2010, just as his fund opened a position in HDFC Bank Limited (NYSE:HDB), Ken Fisher gave an interview to Forbes, noting that the world had entered a phase where 25% of global GDP was from emerging markets nations. He also added that this number was not only growing, but growing rapidly across the board. Fisher also noted that data on companies in emerging markets had become more accessible on the internet, providing American investors more knowledge about these firms, and giving them more choices.

HDFC Bank Limited (NYSE:HDB) provides banking and financial products and services to individuals and businesses in India, Bahrain, Hong Kong, Singapore, and Dubai. The company operates through treasury, retail banking, wholesale banking, and insurance business.

2. Emerson Electric Co. (NYSE:EMR

Fisher Asset Management’s Stake: $954 Million

Emerson Electric Co. (NYSE:EMR) has been featured in the 13F portfolio of Fisher Asset Management since 2010. Back then, the stake had comprised just under 5 million shares. The fund trimmed this stake down to minute levels after 2012. However, in late 2022, it started buying up shares in the company again as the AI boom took off. From 160,000 shares in the fourth quarter of 2022, this position has grown to more than 7 million shares at the end of the fourth quarter of 2025. Compared to filings for the third quarter of 2025, the fund increased its stake in the firm by 15% between October and December 2025.

In early February, Emerson Electric Co. (NYSE:EMR) raised EPS guidance to $6.40–$6.55 for 2026, citing AI-enabled products and robust North America orders as growth drivers. Fisher understands the core business strength of the firm. In his 2010 book titled The Ten Roads to Riches: The Ways Rich People Got Rich… and How You Can Too, he underlined that companies that sell a wide range of industrial equipment across many industries often smooth out the worst of cyclical downturns.

Emerson Electric Co. (NYSE:EMR) is a technology and software company that provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. It operates through final control, measurement and analytical, discrete automation, safety and productivity, control systems and software, and test and measurement segments.

1. Broadcom Inc. (NASDAQ:AVGO)

Fisher Asset Management’s Stake: $4.8 Billion

Broadcom Inc. (NASDAQ:AVGO) is a relatively newer addition to the 13F portfolio of Fisher Asset Management, given that it is a major position, comprising over 1.6% of the total portfolio, when other major positions have been held by the fund for more than a decade or more. However, the company has more than pulled its weight, crossing over $1 trillion in market capitalization at the end of 2024, becoming part of an elite group of companies on the US stock market to achieve this feat. Fisher had opened a position in the company in the last quarter of 2021, just before the AI boom led to a crazy spike in the stock price of Broadcom. This holding, comprising close to 8 million shares, rose to more than 23 million shares at the end of 2024. However, it has been trimmed since then. At the end of the fourth quarter of 2025, the fund held close to 14 million shares in the firm.

Earlier this month, Broadcom Inc. (NASDAQ:AVGO) projected that AI chip revenue for the firm would surpass $100 billion in 2027 as AI demand accelerates. The chip firm guided for consolidated revenue of around $22 billion in Q2 2026, up 47% year-on-year. It also expects semiconductor revenue of approximately $14.8 billion, with AI semiconductor revenue projected at $10.7 billion, up roughly 140% year-on-year.

Broadcom Inc. (NASDAQ:AVGO) designs, develops, and supplies various semiconductor devices and infrastructure software solutions internationally. It offers networking connectivity, such as custom silicon solutions, ethernet switching and routing, ethernet NIC controllers, physical layer devices, and fiber optic components.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.